Yunfeng Gao, Weiyang He, Xueyang He, Yilong Huang, Xin Gou
Department of Urology Department of Dermatology, the First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chong Qing, China.
Medicine (Baltimore). 2017 Jul;96(27):e7368. doi: 10.1097/MD.0000000000007368.
Prostate cancer (PCa) patients initiating androgen deprivation therapy (ADT) are suffering from adverse effects; exercise has been proposed as a treatment to relieve adverse effects of ADT, available meta-analysis has proved exercise improves quality of life, and therapy caused fatigue; recently, some high-quality trials have been conducted in order to get more assessment; we conduct an updated meta-analysis to evaluate feasibility that exercise relieves adverse effects in PCa patients initiating ADT.
A systematic article search was performed from Cochrane Library, MEDLINE, EMBASE, and PubMed databases up to March 10, 2017. Outcomes included changes in body composition, physical function, bone health and cardiometabolic changes. We conduct subgroup analysis to analyze the duration and type of exercise correlated with the effect and calculated using standard mean difference (SMD) and corresponding 95% confidence intervals (CI).
Fifteen studies involving 1135 patients were included in our meta-analysis, and significant positive effects were found in body strength (leg press (SMD: 0.78 (95%CI: 0.57-0.99, P <.00001, I = 0%)), chest press (SMD: 0.71 (95%CI: 0.50-0.92, P <.00001, I = 0%)), exercise tolerance (VO2 peak SMD: 0.35 (95%CI: 0.04-0.66, P = .03, I = 0%) in 6 months and SMD: 0.59 (95%CI: 0.16-1.03, P = .007, I = 0% over 6 months)), fatigue (SMD: 0.84 (95%CI: -1.43 to 3.10, P = .85, I = 51%) in 6 months and SMD: -9.3 (95%CI: -16.22 to -2.39, P = .0030, I = 49%) over 6 months)), ADT-caused obesity (body mass index SMD: -0.33 (95%CI: -0.55 to -0.12, P = .002, I = 38% in 6 months and SMD: -0.59 95%CI: -1.02 to 0.17, P = .006, I = 25% over 6 months)), and sex function (SMD: 0.66 (95%CI: 0.35-0.97, P <.00001, I = 2%). There were no evidence of benefit for cardiometabolic changes and bone health. No systematic difference was observed between resistance exercise training (RET) and aerobic exercise training (AET) in ADT-caused obesity, fatigue, and exercise tolerance CONCLUSION:: Exercise can significantly improve the upper and lower muscle strength, increase exercise tolerance, help PCa patients receiving ADT control their body fat mass, BMI, and keep the sex function. ADT-related fatigue is correlated with exercise duration time. No differences were observed in LBM, bone mineral density, and any other metabolic blood markers. Available data show that there is no difference between AET and RET.
开始接受雄激素剥夺疗法(ADT)的前列腺癌(PCa)患者会遭受不良反应;运动已被提议作为缓解ADT不良反应的一种治疗方法,现有的荟萃分析已证明运动可改善生活质量以及治疗引起的疲劳;最近,已开展了一些高质量试验以进行更多评估;我们进行了一项更新的荟萃分析,以评估运动缓解开始接受ADT的PCa患者不良反应的可行性。
截至2017年3月10日,从Cochrane图书馆、MEDLINE、EMBASE和PubMed数据库进行了系统的文献检索。结局包括身体成分、身体功能、骨骼健康和心脏代谢变化。我们进行亚组分析以分析与效果相关的运动持续时间和类型,并使用标准均数差(SMD)和相应的95%置信区间(CI)进行计算。
我们的荟萃分析纳入了15项研究,涉及1135名患者,在身体力量方面发现了显著的积极效果(腿部推举(SMD:0.78(95%CI:0.57 - 0.99,P<.00001,I = 0%))、胸部推举(SMD:0.71(95%CI:0.50 - 0.92,P<.00001,I = 0%))、运动耐力(6个月时VO2峰值SMD:0.35(95%CI:0.04 - 0.66,P = .03,I = 0%),6个月以上时SMD:0.59(95%CI:0.16 - 1.03,P = .007,I = 0%))、疲劳(6个月时SMD:0.84(95%CI: - 1.43至3.10,P = .85,I = 51%),6个月以上时SMD: - 9.3(95%CI: - 16.22至 - 2.39,P = .0030,I = 49%))、ADT引起的肥胖(体重指数SMD: - 0.33(95%CI: - 0.55至 - 0.12,P = .002,I = 38%,6个月时),6个月以上时SMD: - 0.59 95%CI: - 1.02至0.17,P = .006,I = 25%))和性功能(SMD:0.66(95%CI:0.35 - 0.97,P<.00001,I = 2%)。没有证据表明对心脏代谢变化和骨骼健康有益。在ADT引起的肥胖、疲劳和运动耐力方面,阻力运动训练(RET)和有氧运动训练(AET)之间未观察到系统差异。结论:运动可显著提高上下肢肌肉力量,增加运动耐力,帮助接受ADT的PCa患者控制体脂量、体重指数并保持性功能。ADT相关疲劳与运动持续时间相关。在去脂体重、骨密度和任何其他代谢血液标志物方面未观察到差异。现有数据表明AET和RET之间没有差异。